January 7, 2021
LEO Pharma said on January 6 that it has received Japanese regulatory approval for a new foam formulation of its psoriasis treatment Dovobet (calcipotriol hydrate + betamethasone dipropionate). Dovobet is already available in ointment and gel forms. The new version...read more